Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05789004

Efficacy of Tooth Bleaching With 35% and 6% Hydrogen Peroxide in Primary Dentition

Efficacy of Tooth Bleaching With 35% and 6% Hydrogen Peroxide in Primary Dentition: Study Protocol for a Randomized Controlled Clinical Trial

Status
Not Yet Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
38 (estimated)
Sponsor
University of Nove de Julho · Academic / Other
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Accepted

Summary

The aesthetics of dental elements generates great psychological and social impacts, both in the deciduous and permanent dentition. One of the techniques widely used to visually improve the appearance of teeth is bleaching. Bleaching can be performed both at home and in a dental office. In office whitening, the technique used consists of applying the whitening gel to the dental surfaces in concentrations ranging from 25% to 50% of hydrogen peroxide. However, recent studies show that low and medium concentration bleaching agents based on hydrogen peroxide have been effective and present a lower risk of sensitivity to the patient. In view of the above, this study aims to carry out a controlled and randomized clinical trial to compare the effectiveness of dental bleaching in deciduous teeth with hydrogen peroxide at concentrations of 35% and 6%. For this, 38 patients aged 03 to 06 years will be selected, allocated in 2 groups (G1 - Hydrogen Peroxide 35%, n=19 and G2- Hydrogen Peroxide 6%, n=19). Bleaching will be carried out in up to three sessions, with an interval of 7 days between them and the evaluation of color and tooth sensitivity will be carried out 48 hours after each bleaching session. The color assessment will be measured using a digital spectrometer and tooth sensitivity using the Pain Level Scale (Wong-Baker Faces®). Descriptive statistical analysis will be carried out, containing the mean and standard deviation in the calculation and normality and homogeneity tests will be carried out, for subsequent adequate statistical analysis. As a result, it is expected that there is no significant difference between the groups in terms of color variation and that the low-concentration bleaching group has the lowest sensitivity index.

Conditions

Interventions

TypeNameDescription
PROCEDURETooth Bleaching with Whiteness HP Automixx 35%* Clinical examination and taking the initial shade of the tooth with Vita Easyshade®; * Sensitivity/pain recording using the Pain Level Scale (Wong-Baker Faces®); * Prophylaxis with a Robson brush and prophylactic paste; * Application of lip balm on the patient's lips; * Placement of the labial retractor; * Application of the gingival barrier; * Application of Whiteness HP Automixx 35% whitening gel; * In the session, a single application of the gel will be carried out and where it will remain on the surface of the tooth for 15 min; * The gel must be removed from the teeth with a sucker and the teeth cleaned with gauze; * Sensitivity/pain recording using the Pain Level Scale (Wong-Baker Faces®); * The second bleaching session will be carried out 7 days after the first one and, if necessary, a third session can be carried out 7 days after the second one.
PROCEDURETooth Bleaching with Whiteness HP Automixx 6%* Clinical examination and taking the initial shade of the tooth with Vita Easyshade®; * Sensitivity/pain recording using the Pain Level Scale (Wong-Baker Faces®); * Prophylaxis with a Robson brush and prophylactic paste; * Application of lip balm on the patient's lips; * Placement of the labial retractor; * Application of the gingival barrier; * Application of Whiteness HP Automixx 6% whitening gel; * In the session, a single application of the gel will be carried out and where it will remain on the surface of the tooth for 15 min; * The gel must be removed from the teeth with a sucker and the teeth cleaned with gauze; * Sensitivity/pain recording using the Pain Level Scale (Wong-Baker Faces®); * The second bleaching session will be carried out 7 days after the first one and, if necessary, a third session can be carried out 7 days after the second one.

Timeline

Start date
2025-03-01
Primary completion
2025-08-20
Completion
2026-03-20
First posted
2023-03-29
Last updated
2024-11-04

Source: ClinicalTrials.gov record NCT05789004. Inclusion in this directory is not an endorsement.